Secondary Immunodeficiency (SID)Symptoms, Doctors, Treatments, Advances & More
Learn About Secondary Immunodeficiency (SID)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Donald Vinh practices in Vancouver, Canada. Mr. Vinh is rated as an Elite expert by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Secondary Immunodeficiency (SID), Primary Immunodeficiency (PID), Severe Acute Respiratory Syndrome (SARS), COVID-19, and Bone Marrow Transplant.
The Medical College Of Wisconsin Inc
Julie Biller is a Pulmonary Medicine specialist and a Pediatric Pulmonologist in Milwaukee, Wisconsin. Dr. Biller is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Lung Metastases. Dr. Biller is currently accepting new patients.
Silvia Ramon-Sanchez practices in Madrid, Spain. Ms. Ramon-Sanchez is rated as an Elite expert by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Secondary Immunodeficiency (SID), Sudden Infant Death Syndrome (SIDS), Primary Immunodeficiency (PID), Common Variable Immune Deficiency, and Bone Marrow Transplant.
Summary: Multiple myeloma is a cancer of the plasma cells in the bone marrow. The main aim of this study is to learn how well the Immune Globulin Infusion (human), 10 percentage (%) (IGI, 10%) can help prevent infections in participants with multiple myeloma receiving B-cell maturation antigen (BCMA) x cluster of differentiation 3 (CD3) directed bispecific antibody therapy. Participants will be randomly as...
Summary: In this study, multiple myeloma participants with secondary immunodeficiency (SID) will be treated with HyQvia according to their clinic's standard practice. The study's main aim is to look into infusion parameters of HyQvia administration.